ADH4 - - ,

Ling Li1, Yong-Ta Huang1, Li-Ting Wang2

  • 1Department of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.

BMC cancer
|August 1, 2024
PubMed
概括

酒精脱酶4 (ADH4) 在肝细胞癌 (HCC) 中被下调,表明其作为诊断和预后生物标志物的潜力. 低ADH4表达与预后不佳相关,并建议它作为HCC免疫治疗的目标.